In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the ...

Key Takeaways Two Boston Scientific heart devices have been linked to serious injuries and deathsOne device may fail to ...

Boston Scientific faces scrutiny as the FDA issues warnings on two heart devices linked to injuries and deaths. The agency ...

Boston Scientific Corporation (NYSE:BSX) is one of the 13 Best Large Cap Stocks to Buy Right Now.

Boston Scientific bumped up its financial forecasts for the remainder of this year after reporting double-digit growth across multiple medtech segments. | The company logged a 22.8% increase in ...

Boston Scientific beats Q2 estimates, posts 22.8% revenue growth, and raises full-year outlook on strong cardiovascular and MedSurg performance.

Abbott is doubling down on the structural heart space as it aims to gain ground in valve replacements following the recent global exit of Boston Scientific. CEO Robert Ford said sales of its ...

Boston Scientific Corporation (NYSE:BSX) Q2 2025 Earnings Call Transcript July 23, 2025 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.75, expectations were $0.725 ...

Boston Scientific shares have increased 15% since the beginning of the year, while the S&P's 500 index has increased slightly more than 7%. The stock has increased 32% in the last 12 months.

Boston Scientific raised its annual profit forecast on Wednesday, banking on strong demand for its heart devices, and trimmed its expectation for tariff-related costs to half of the previously ...

Boston Scientific (NYSE:BSX) is set to announce its earnings on Wednesday, July 23, 2025.

About Boston Scientific Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world.